21 min listen
Introducing Run the List: the latest hem onc news - Earlier lung screening doubles eligibility, lifestyle reduces breast cancer risk regardless of gen…
FromBlood & Cancer
Introducing Run the List: the latest hem onc news - Earlier lung screening doubles eligibility, lifestyle reduces breast cancer risk regardless of gen…
FromBlood & Cancer
ratings:
Length:
11 minutes
Released:
Jul 14, 2020
Format:
Podcast episode
Description
The latest news for hematology and oncology professionals. In this episode: USPSTF: Earlier lung cancer screening can double eligibility * Review and comment on the USPSTF site: https://bit.ly/3fppiD7* National Lung Screening Trial https://bit.ly/2CvNRQt Lifestyle choices may reduce breast cancer risk regardless of genetics* Read the article on MDedge: https://bit.ly/2ZrsWqN * Read the original research: https://bit.ly/3etRLGx (JAMA Netw Open. 2020;3(4):e203760). FDA approves oral therapy for myelodysplastic syndromes, CMML * Read the FDA news release: https://bit.ly/2WeUIVb Commentary: 'Doc, Can I Get a Mask Exemption?' * Read the full commentary from Dr. Rizzo: https://wb.md/2Wfoh9i* Read the CDC Recommendations: https://bit.ly/304OTed * Read more about Dr. Albert Rizzo: https://bit.ly/3j2QDgW For more MDedge Podcasts go to https://www.mdedge.com/podcasts/ Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeHemOnc
Released:
Jul 14, 2020
Format:
Podcast episode
Titles in the series (100)
When to refer for CAR T-cell therapy: Chimeric antigen receptor (CAR) T-cell therapy is one of the hottest advances in lymphoma treatment, but who should get it and what does the process look like? , of the Cleveland Clinic helps answer those questions on the podcast. She joins Blood... by Blood & Cancer